Fenofibric Acid Capsule, Delayed Release
Product Images NDC 62332-244

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fenofibric Acid (NDC 62332-244). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Fenofibric Structure1)

Chemical structure of fenofibric acid illustrating its molecular configuration, including aromatic rings, a chlorine atom, and ester and carboxylate functional groups.*

FDA Label Image

Fenofibric-45mg (Fenofibric 45mg)

Label for Fenofibric Acid 45 mg delayed-release capsules from Alembic Pharmaceuticals Inc. The label shows the NDC 62332-244-30 and indicates a package of 30 capsules. It includes storage instructions, child-resistant packaging info, manufacturer details, and a barcode.*

FDA Label Image

Fenofibric-135mg (Fenofibric 135mg)

Label for Fenofibric Acid Delayed-Release Capsules, USP 135 mg by Alembic Pharmaceuticals Inc. The label includes NDC 62332-245-30, states a 30-capsule count, and features dosage warnings about the capsule seal and storage instructions. The label also shows manufacturing details and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.